Looks like Milton are struggling to raise the cash |
LSE % Gainers Top Lists
EPIC Name %
HUI Hydrogen Utopia +56%
RGD Real Good Food +50%
MII Milton Capital +48%
OBI Ondine Biomedical +31%
PXEN Prospex Energy +12%
Yes Solarno.
MII are up 48.3% today, rising 0.35p to 1.075p (1p - 1.15p), third on the top risers board.
Coincidentally, PXEN are fifth top riser. |
It’s a very good team Hedgehog and as they say some excellent oil and gas opportunities are available |
A very positive announcement |
 20/10/2023 15:16 UK Regulatory (RNS & others) Milton Capital PLC Half-year Report LSE:MII Milton Capital Plc
"Unaudited interim results for the period ended 31 July 2023
Milton Capital Plc ("Milton" or the "Company") is pleased to announce its interim results for the six months ending 31 July 2023 ("The Period").
The Interims Report will shortly be available to view on the Company's website.
Milton is a company incorporated and registered in England and Wales under the Companies Act 2006 and is a SPAC listed on the Standard segment of the London Stock Exchange. Milton was formed with the intention to identify and acquire a suitable business opportunity or opportunities and undertake an acquisition or merger or a series of acquisition or mergers. These Interim results have not been audited or reviewed by the Company's auditors.
Highlights:
-- The Company recorded a loss before tax of GBP33,841 and had cash balances of GBP910,589 at the end of the period.
-- Search for a suitable acquisition target continues.
Enquiries
Peterhouse Capital Limited
Financial Adviser
Guy Miller Tel: +44 (0) 20 7469 0930
Corporate Broker
Lucy Williams/ Duncan Vasey Tel: +44 (0) 20 7469 0930
CHAIRMAN'S STATEMENT
The past half-year has presented challenges in the capital markets due to the upward trend in interest rates, leading to a general slowdown in markets. The heightened uncertainties have made investors exercise caution, impacting our ability to identify a suitable RTO (Reverse Takeover) candidate. Nevertheless, we are confident in the Company's long-term prospects, and we are actively exploring all avenues to create shareholder value. During this period, we are committed to cost-efficiency, as we persist in our quest for a suitable acquisition target. Further updates regarding our acquisition search process will be provided in due time.
Malcolm Burne
Executive Director
Chairman
Responsibility Statement
We confirm that to the best of our knowledge:
-- the Interim Report has been prepared in accordance with International Accounting Standards 34, Interim Financial Reporting, as adopted by the EU.
-- gives a true and fair view of the assets, liabilities, financial position and profit/loss of the Group.
-- the Interim Report includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the set of interim financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year.
-- the Interim Report includes a fair review of the information required by DTR 4.2.8R of the Disclosure and Transparency Rules, being the information required on related party transactions.
-- The Interim Report was approved by the Board of Directors and the above responsibility statement was signed on its behalf by:
Eran Zucker
Non-Executive Director
20 October 2023 ..." |
ASHI's proposed RTO is now intended to be a DOUBLE RTO, valued at over £175M. including the £135M. Cell Therapy valuation and ASHI's shell value:-
24/08/2023 07:00 UK Regulatory (RNS & others) Ashington Innovation PLC Heads of Terms Signed for the Acquisition of Calon LSE:ASHI Ashington Innovation Plc
"Heads of Terms Signed for the Acquisition of Calon Cardio-Technology Limited, subject to the Completion of the Reverse Takeover of Cell Therapy Limited
Ashington Innovation plc (LSE: ASHI; FSE: 6FW), a special purpose acquisition company, is pleased to announce it has entered into a non-binding heads of terms agreement with Calon Cardio-Technology Limited ("Calon"), to acquire 100% of the outstanding shares in Calon in an all-share transaction. The acquisition is subject to the completion of the proposed reverse takeover of Cell Therapy Limited ("CTL") ...
Following recent discussions, on 23 August 2023 Ashington entered a non-binding heads of terms agreement with Calon for the acquisition of 100% of the issued share capital of Calon for a purchase price of GBP39 million, to be satisfied by the allotment and issue of new ordinary shares in Ashington Innovation PLC to the shareholders of Calon. ..." |
The shell company ASHI floated at 3p per share in June, market cap. £1.841M., compared to net cash of £717K., including its net IPO proceeds.
That didn't look cheap, but to its credit it has suspended (at 2.75p) for a RTO, valued at well over £100M., just two and a half months later:-
06/06/2023 08:01 UK Regulatory (RNS & others) Ashington Innovation PLC Ashington - Admission to trading on the LSE LSE:ASHI Ashington Innovation Plc
"Admission to trading on the London Stock Exchange
Ashington Innovation plc, a special purpose acquisition company ("SPAC") aiming to benefit from favourable price conditions for companies in the financial services technology (fintech) and deep technology (deep tech) sectors, is pleased to announce that its entire issued ordinary share capital, consisting of 61,397,900 ordinary shares, was admitted to the Standard Listing Segment of the Official List of the Financial Conduct Authority, and to trading on the London Stock Exchange's Main Market for listed securities at 8.00 a.m. today, under the ticker "ASHI". ...
About Ashington Innovation plc
Ashington Innovation PLC is a special purpose acquisition company (SPAC), formed with the intention of acquiring businesses operating in the technology sector, in particular the financial services technology and deep technology sectors.
The Company believes that in the increasingly fast-changing global environment there will be an abundance of opportunities to acquire existing businesses in the technology sector, and in particular businesses that possess and utilise proprietary technologies and own applicable intellectual property.
The Company is not limited to any specific geographic region in identifying its target companies. Both Jason Drummond and Jason Smart, directors of the Company, bring a wealth of experience in founding and building successful companies across a diverse range of sectors.
www.ashingtoninnovationplc.com "
17/08/2023 08:10 UK Regulatory (RNS & others) Ashington Innovation PLC Heads of Terms Signed LSE:ASHI Ashington Innovation Plc
"Heads of Terms Signed
Proposed Reverse Takeover of Cell Therapy Limited
Suspension of Listing
Conditional Acquisition of Cell Therapy Limited
Ashington Innovation (LSE:ASHI), the Special Purpose Acquisition Company (SPAC) established to acquire businesses primarily in the technology sector, is pleased to announce that the Company has entered into a non-binding term sheet (the "Term Sheet") with Cell Therapy Limited ("Cell Therapy") pursuant to which Ashington Innovation will acquire 100% of the total issued equity for GBP135 million in an all share transaction (the "Transaction"). Cell Therapy is a clinical stage biotechnology firm with a portfolio of patented cellular medicines with a lead program that successfully completed an early-stage human clinical trial in heart failure.
The Directors of Ashington Innovation consider the Transaction to represent a transformational, value enhancing transaction for shareholders, which is fully aligned with the Company's growth strategy. Cell Therapy's product and patent portfolio provides a platform to develop leading medicines, which have been validated in a human clinical trial and through granted patents in the US, UK, EU and Asia.
To fund the Transaction, Ashington Innovation will be seeking to carry out a placing of new ordinary shares to new and existing investors ("Placing") to raise funds of up to GBP3 million to finance the drug development program and working capital. As such, the Transaction is conditional, inter alia, on the completion of due diligence, definitive sale and purchase documentation, obtaining the necessary regulatory approvals from the FCA and the Takeover Panel, a successful Placing, and the passing of necessary resolutions to approve the Transaction by the shareholders of the Company at a duly convened general meeting.
Suspension of Listing
As the proposed acquisition, if it proceeds, will constitute a Reverse Takeover under the Listing Rules, the Company's ordinary shares shall be suspended pending the publication of a prospectus or an announcement that the proposed Transaction is not proceeding. Any restoration of the listing is subject to the approval of the FCA.
At this stage, there can be no guarantee that the proposed Transaction will complete nor as to the final terms of the proposed Transaction. Further announcements and updates will be made in due course.
Jason Smart, Founder of Ashington Innovation, commented: "We are delighted to have agreed a heads of terms to acquire Cell Therapy. During the past few months, we have reviewed numerous projects and believe the proposed acquisition meets our stated objective of identifying a potentially extremely valuable entity capable of sustainable development and with significant technological advantages. The directors believe that the regenerative medicine and biotechnology sector presents compelling opportunities to create value for shareholders and the proposed acquisition presents a high-quality target with an experienced and expert leadership. This is a very exciting opportunity to bring a scalable business with a strong track record to the public markets." "
Ashington Innovation (ASHI):-
This shows the enormous upside of MII, a shell which like ASHI is targeting some extremely cutting edge areas.
But at just 0.8p (market cap. £800K.), MII is trading at under half the market cap. of ASHI's, despite having more cash than ASHI: indeed actually trading at below the level of its current cash, which is very unusual for a shell. |
And no MII trade or volume showing for today.
Which I think makes the MII fall yesterday a clear-cut case of 'silly games' from the market makers.
Of course they may be hoping that a much wider spread (at the moment) puts off buyers. Though it doesn't have to.
Most shells are illiquid: but you can buy them with the intention of holding through suspension for the RTO.
After that, a £1M. market cap. can be transformed overnight into a £100M. market cap., and liquidity can follow suit.
But not all shell investors have that sort of sense and discipline, which is why you can get such significant shell undervaluations: if MII wasn't so illiquid, then it wouldn't be so cheap. |
Well, there's still no further MII trade or volume showing for today, an hour after market close.
So unless something is reported even later today, or reported a day late tomorrow, then it looks like today's MII fall is just 'silly games' by the market makers. |
Recent Share Trades for Milton Capital (MII)
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
10-Aug-23 13:43:37 0.89 54,668 Buy* 0.70 0.90 486.55 O
Interesting MII share price movement today, following today's bullish 7a.m. RNS.
The market makers opened the stock down 8.57% at 0.8p mid price, by dropping the bid price to 0.7p from 0.85p; though the ask price is unchanged at 0.9p, and there has been just one modest trade so far today: a buy for 0.89p.
So is there a worked sell in the background, or is it just mm games in light of a severe stock shortage?
Let's see what shows at the end of today, or tomorrow. |
Recent Share Trades for Milton Capital (MII)
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
09-Aug-23 10:26:30 0.895 1,000,000 Unknown* 0.85 0.90 8,950 O
09-Aug-23 09:22:19 0.895 500,000 Buy* 0.85 0.90 4,475 O
Two relatively large MII buys today, both for near the full asking price of 0.9p.
1.5M. shares traded is the second largest share trading day in MII's history; and accounts for 1.5% of MII's shares in issue.
Coming so soon after the AGM this looks like a very bullish signal, and suggests that something very big and exciting could be happening here imminently.
With this buying recently the market makers must surely be just about out of stock, and anything below the IPO price of a penny looks dirt cheap.
So at just 0.875p MII looks like a supremely compelling buy opportunity. |
An RTO is simply an alternative way to float on the stock market, and some of the world's largest companies have come to market via this route.
Including WPP, current market cap. c. £8.5 billion:-
" ... WPP plc is a British multinational communications, advertising, public relations, technology, and commerce holding company headquartered in London, England. It was the world's largest advertising company, as of 2019.[4] WPP plc owns many companies, which include advertising, public relations, media, and market research networks such as AKQA, BCW, CMI Media Group, Essence Global, Finsbury, Grey, Hill+Knowlton Strategies, Mindshare, Ogilvy, Wavemaker, Wunderman Thompson, and VMLY&R. It is one of the "Big Four" agency companies, alongside Publicis, The Interpublic Group of Companies, and Omnicom Group.[5] WPP has a primary listing on the London Stock Exchange, and is a constituent of the FTSE 100 Index.[6]
On 14 April 2018, Martin Sorrell retired 33 years after founding the company. Roberto Quarta is chairman.[7] Mark Read is CEO.[8]
History
The company was founded as Wire and Plastic Products plc to manufacture wire shopping baskets in 1971. In 1985 Martin Sorrell and Preston Rabl,[9] searching for a listed company through which to build a worldwide marketing services company, bought a controlling stake.[10][11] ..." |
2023 is looking like it could be the year of AI (artificial intelligence), so an AI RTO into MII could be very timely. And very profitable for MII shareholders.
"The state of AI in 2023: Generative AI’s breakout year
August 1, 2023 | Survey
As organizations rapidly deploy generative AI tools, survey respondents expect significant effects on their industries and workforces.
McKinsey & Company – Listen to the article: The state of AI in 2023: Generative AI’s breakout year
The latest annual McKinsey Global Survey on the current state of AI confirms the explosive growth of generative AI (gen AI) tools. Less than a year after many of these tools debuted, one-third of our survey respondents say their organizations are using gen AI regularly in at least one business function. Amid recent advances, AI has risen from a topic relegated to tech employees to a focus of company leaders: nearly one-quarter of surveyed C-suite executives say they are personally using gen AI tools for work, and more than one-quarter of respondents from companies using AI say gen AI is already on their boards’ agendas. What’s more, 40 percent of respondents say their organizations will increase their investment in AI overall because of advances in gen AI. The findings show that these are still early days for managing gen AI–related risks, with less than half of respondents saying their organizations are mitigating even the risk they consider most relevant: inaccuracy. ..." |
Recent Share Trades for Milton Capital (MII)
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
07-Aug-23 16:34:18 0.87 250,000 Sell* 0.85 0.90 2,175 O
07-Aug-23 12:54:24 0.87 250,000 Sell* 0.85 0.90 2,175 O
So there was also a second MII buy later on this afternoon, again incorrectly showing as a sell at just below mid.
And interestingly, this buy was booked after the close of market.
This suggests that it was part of a larger buy order being worked, but that only part of it could be filled. |
MII's AGM was held in London today, at 11a.m.
Shortly afterwards, someone bought 250,000 MII shares (incorrectly showing as a sell at just below mid):-
Recent Share Trades for Milton Capital (MII)
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
07-Aug-23 12:54:24 0.87 250,000 Sell* 0.85 0.90 2,175 O
It could be that someone liked what they heard at the AGM, with regard to RTO prospects.
And this shell certainly has the potential for a very attractive RTO deal, in the near term, at a large premium (current share price 0.875p). |
07/08/2023 13:05 UK Regulatory (RNS & others) Milton Capital PLC Result of AGM LSE:MII Milton Capital Plc
"Milton Capital Plc announces that at the Annual General Meeting ("AGM") held earlier today all resolutions were duly passed. The numbers of votes for each resolution are presented below:
Resolution Total For Total Against Withheld
(No. as noted
on proxy
form)
No. of votes % of vote No. of votes % of vote No. of votes
------------- ---------- ------------- ---------- -------------
1 23,000,000 99.96 9,370 0.04 Nil
------------- ---------- ------------- ---------- -------------
2 23,000,000 99.96 9,370 0.04 Nil
------------- ---------- ------------- ---------- -------------
3 23,000,000 99.96 9,370 0.04 Nil
------------- ---------- ------------- ---------- -------------
4 23,000,000 99.96 9,370 0.04 Nil
------------- ---------- ------------- ---------- -------------
5 23,000,000 99.96 9,370 0.04 Nil
------------- ---------- ------------- ---------- -------------
6 23,000,000 99.96 9,370 0.04 Nil
------------- ---------- ------------- ---------- -------------
7 23,000,000 99.96 9,370 0.04 Nil
------------- ---------- ------------- ---------- -------------
The full text of the resolutions can be found in the Notice of Annual General Meeting, which is available on the Company's website at: hxxp://milton-capital.co.uk .
Enquiries:
Milton Capital plc info@milton-cpaital.co.uk
Directors or
Malcolm Burne Miltoncapitalplc@gmail.com
Eran Zucker
Peterhouse Capital Limited
Financial Adviser and
Brefo Gyasi / Guy Miller +44 (0)20 7469 0930
Corporate Broker
Lucy Williams / Duncan
Vasey" |
30/01/2023 15:50 UK Regulatory (RNS & others) Milton Capital PLC Holding(s) in Company LSE:MII Milton Capital Plc
"... 3. Details of person subject to the notification obligation (iv)
Name Flare Capital ...
Resulting situation
on the date
on which threshold
was crossed
or reached 3.25% 3,250,000 ..."
I wonder if today's MII trades have anything to do with Flare Capital, who reported a notifiable interest in MII in January?
Either way, FC are an impressive MII shareholder, who could be very useful with American contacts:- |
Recent Share Trades for Milton Capital (MII)
Date Time Trade Prc Volume Buy/Sell Bid Ask Value
03-Aug-23 16:35:24 0.85 30,000 Sell* 0.85 0.90 255.00 UT
03-Aug-23 13:47:40 0.85 5,000,100 Sell* 0.85 0.90 42.50k O
03-Aug-23 13:48:39 0.85 5,000,100 Sell* 0.85 0.90 42.50k O
03-Aug-23 13:47:40 0.085 -5,000,100 Unknown* 0.85 0.90 -4,250 O
03-Aug-23 13:47:40 0.085 5,000,100 Sell* 0.85 0.90 4,250 O
Some interesting MII trades today, ahead of the AGM on Monday (7th. August).
With 100 million MII shares in issue, a trade of over five million shares represents over 5% of MII's equity.
And today's MII trading volume is by far the highest in the company's history. |
Poor stock market conditions tend to make it harder to IPO, increasing the attractions of the RTO route, and increasing the bargaining power of shells like MII.
And meanwhile, the valuations of RTO targets for shells tend to be depressed.
So ironically, the s.p.s of shells like MII can become depressed at the same time as they are in effect becoming more valuable: more capable of cutting a cracking RTO deal on great terms - i.e. a better shell valuation and lower target valuation, and great quality targets.
Which makes a shell like MII - with both great cash underpinning and great deal prospects - a great place to 'park funds' at the moment.
Many investors may wish to reduce their exposure to shares in companies with trading businesses, but holding cash for months doesn't give any real direct upside - certainly in the short term.
MII though has both underpinning, and great potential upside.
And you don't have to worry about funds being tied up here for a while if you won't be using them anyway.
28/04/2023 15:15 UK Regulatory (RNS & others) Milton Capital PLC Annual Financial Report LSE:MII Milton Capital Plc
" ... Milton Capital Plc - Chairman's Statement for the period ended 31 January 2023
Dear Shareholders,
The board of Milton Capital Plc is pleased to present its inaugural Annual Report to shareholders.
I am delighted to announce that our cash shell with a focus on technology has successfully completed its listing on the London Stock Exchange on 4th October 2022, and we are now officially a public company. This marks an important milestone for our business and opens up new opportunities for us to create value for our shareholders.
As a cash shell, our primary objective is to identify and invest in attractive businesses or assets that have the potential to generate strong returns for our investors. With our focus on technology, we are particularly interested in high-growth sectors such as AI, edge computing, quantum computing, machine learning, automation, robotics, blockchain, nanomaterials and the exploitation of space. We believe that the rapid pace of technological change and disruption presents significant opportunities for value creation, and we will be actively seeking out innovative businesses and technologies that have the potential to generate significant returns for our shareholders.
Our experienced management team has a proven track record of identifying and executing successful investments, and we believe that our team's expertise and network will be a key advantage as we seek out new investment opportunities in the technology sector. We will continue to be guided by our core principles of integrity, transparency, and accountability as we navigate the investment landscape and evaluate potential investments in the technology space.
We believe that building strong relationships with our investors is essential to our success as a public company, and we are committed to earning and maintaining your trust. We are also committed to maintaining open and transparent communication with our shareholders, and we will provide regular updates on our progress and any material developments. It is important to us that our shareholders have a clear understanding of our strategy and investment approach, and we will be as forthcoming as possible with information that is relevant to our performance. It is worth noting that this statement has been drafted by ChatGPT, a language model trained by OpenAI, but it has been reviewed and approved by our management team to ensure that it accurately reflects our vision and objectives.
Our commitment to technology extends beyond just investing in innovative businesses and assets. As evidenced by our use of ChatGPT to draft this statement, we are constantly exploring new and emerging technologies that can help us achieve our objectives more efficiently and effectively. We believe that our use of cutting-edge technology reflects the ethos of our company and our dedication to remaining at the forefront of technological advancement. We are committed to leveraging technology in all areas of our business to drive growth and create value for our shareholders.
In conclusion, I would like to thank our shareholders for their support and confidence in our business. We are excited about the opportunities that lie ahead in the dynamic and rapidly evolving technology sector, and look forward to delivering value for our shareholders as we embark on this new chapter in our journey.
Sincerely,
Eran Zucker
Non-Executive Director
28 April 2023 ...
Investing policy
Milton Capital Plc was formed with the intention to identify and acquire a suitable business opportunity or opportunities and undertake an acquisition or merger or a series of acquisitions or mergers.
The Company intends the main focus of the acquisition strategy to be on the technology sector, in particular: edge computing, quantum computing, artificial intelligence, machine learning, automation, robotics, blockchain, nanomaterials and the exploitation of space.
The Directors see these technologies as having considerable growth potential for the foreseeable future and many of the prospects they have identified are in this sector. The Directors believe that any acquisition target will have at least one of four key components: (i) a strong management team; (ii) an innovative product proposal (iii) revenue enhancing or cost saving capabilities; and (iv) high growth potential. It is anticipated that the main driver of success for the Company will be its focus, during the investment screening process, on the management involved in the potential target companies and the potential value creation that the team of people is capable of realising. The Company intends to own, operate and manage the target acquisitions. Accordingly, where the Directors feel that a target company would benefit from their skills and expertise, they may look to seek representation on the board of the target company.
The Directors believe that their broad, collective experience, together with their extensive network of contacts, will assist them in identifying, evaluating and funding suitable acquisition opportunities. ..." |
"MILTON CAPITAL PLC
The Company's efforts in identifying opportunities will not be limited to a particular industry or geographic location. However, given the collective experience of the Directors, the Company will initially focus on opportunities in the technology sectors.
In particular, the focus within this sector will be on edge computing, quantum computing, artificial intelligence, machine learning, automation, robotics, blockchain, nanomaterials and the exploitation of space; the Directors see these technologies as having considerable growth potential for the foreseeable future and many of the prospects they have identified are in this sector."
Interesting that MII's website reveals that they have identified many prospects.
And at just 0.9p (market cap. £900K.), the company is trading at under its IPO price, and at about the level of its current cash. |
and still are |
Buyers were quick to step in on the drop ! |
The latest Peterhouse offering with very little costs upfront for professionals. |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
